Status:
UNKNOWN
The GOLD Study: G8 in OLDer Patients
Lead Sponsor:
Istituto Oncologico Veneto IRCCS
Collaborating Sponsors:
Roche Pharma AG
Conditions:
Elderly Metastatic Colorectal Cancer Patients
Eligibility:
All Genders
70+ years
Brief Summary
Management of older cancer patients is challenging, due to a lack of good quality evidence to guide treatment decisions, as well as the wide variability in the level of fitness for treatment of elderl...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- New diagnosis of metastatic colorectal cancer, untreated in the metastatic setting
- Age ≥ 70 years
- Availability of clinical data
- Before patient registration, written informed consent must be given according to ICH/GCP, and national/local regulations
Exclusion
Key Trial Info
Start Date :
October 26 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT03449914
Start Date
October 26 2017
End Date
July 1 2024
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Oncologico Veneto IRCCS
Padua, Italy, 35128